Conference Coverage

VIDEO: German screening initiative catches skin cancer sooner


 

FROM THE 2014 WORLD CONGRESS ON CANCERS OF THE SKINS

References

EDINBURGH – Is population screening for skin cancer worthwhile?

Yes, Dr. Eckhard Breitbart said in a debate at the 15th World Congress on Cancers of the Skin. "Screening is not a diagnostic procedure," he noted. But the potential benefits of screening, including a significant reduction in medical costs, outweigh the potential harms related to false negative or false positive findings, added Dr. Breitbart, a dermatologist in Hamburg, Germany.

In an interview at the meeting, Dr. Breitbart reviewed the findings from his study of the impact of a population-based skin cancer screening program in Germany, and he discussed what research is needed to support such screening elsewhere.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

hsplete@frontlinemedcom.com

Recommended Reading

FDA approves oritavancin for skin infections
MDedge Internal Medicine
Mobile teledermatology predicted to be a game changer
MDedge Internal Medicine
VIDEO: Stress and inflammatory skin diseases – Does the science prove a link?
MDedge Internal Medicine
Infliximab may carry a higher infection rate in psoriasis patients
MDedge Internal Medicine
Anti-adalimumab antibodies mean poorer outcomes in psoriatic arthritis
MDedge Internal Medicine
Psoriasis patients post above-average cancer rates
MDedge Internal Medicine
Consider a zero therapy approach to periorificial dermatitis
MDedge Internal Medicine
Field therapy preferred when treating actinic keratoses
MDedge Internal Medicine
Photodynamic therapy clears thin AKs better than cryotherapy
MDedge Internal Medicine
VIDEO: What’s your UV risk today? There’s an app for that
MDedge Internal Medicine